Ethylenecarbodiimide-Fixed Donor Splenocyte Infusions Differentially Target Direct and Indirect Pathways of Allorecognition for Induction of Transplant Tolerance
- 15 July 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 189 (2) , 804-812
Abstract
Strategic exposure to donor Ags prior to transplantation can be an effective way for inducting donor-specific tolerance in allogeneic recipients. We have recently shown that pretransplant infusion of donor splenocytes treated with the chemical cross-linker ethylenecarbodiimide (ECDI-SPs) induces indefinite islet allograft survival in a full MHC-mismatched model without the need for any immunosuppression. Mechanisms of allograft protection by this strategy remain elusive. In this study, we show that the infused donor ECDI-SPs differentially target T cells with indirect versus direct allospecificities. To target indirect allospecific T cells, ECDI-SPs induce upregulation of negative, but not positive, costimulatory molecules on recipient splenic CD11c+ dendritic cells phagocytosing the injected ECDI-SPs. Indirect allospecific T cells activated by such CD11c+ dendritic cells undergo robust initial proliferation followed by rapid clonal depletion. The remaining T cells are sequestered in the spleen without homing to the graft site or the graft draining lymph node. In contrast, direct allospecific T cells interacting with intact donor ECDI-SPs not yet phagocytosed undergo limited proliferation and are subsequently anergized. Furthermore, CD4+CD25+Foxp3+ T cells are induced in lymphoid organs and at the graft site by ECDI-SPs. We conclude that donor ECDI-SP infusions target host allogeneic responses via a multitude of mechanisms, including clonal depletion, anergy, and immunoregulation, which act in a synergistic fashion to induce robust transplant tolerance. This simple form of negative vaccination has significant potential for clinical translation in human transplantation.Keywords
This publication has 50 references indexed in Scilit:
- Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of AllergyThe Journal of Immunology, 2011
- Tolerance Induced by Apoptotic Antigen-Coupled Leukocytes Is Induced by PD-L1+ and IL-10–Producing Splenic Macrophages and Maintained by T Regulatory CellsThe Journal of Immunology, 2011
- Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusionsBiomaterials, 2011
- Negative Selection and Peptide Chemistry Determine the Size of Naive Foreign Peptide–MHC Class II-Specific CD4+ T Cell PopulationsThe Journal of Immunology, 2010
- Ethylenecarbodiimide-Treated Splenocytes Carrying Male CD4 Epitopes Confer Histocompatability Y Chromosome Antigen Transplant Protection by Inhibiting CD154 UpregulationThe Journal of Immunology, 2010
- Tolerogenic Dendritic Cells: All Present and Correct?American Journal of Transplantation, 2010
- ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanismsProceedings of the National Academy of Sciences, 2008
- Transplant Acceptance Following Anti-CD4 Versus Anti-CD40L Therapy: Evidence for Differential Maintenance of Graft-Reactive T CellsAmerican Journal of Transplantation, 2008
- Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathwayJournal of Experimental Medicine, 2006
- Interferon γ Is Required for Activation-induced Death of T LymphocytesJournal of Experimental Medicine, 2002